Drug Type Small molecule drug |
Synonyms BMS 243117, BMS243117 |
Target |
Action inhibitors |
Mechanism LCK inhibitors(Tyrosine-protein kinase LCK inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC20H21ClN4O2S |
InChIKeyFIVXJBFMVDAATB-UHFFFAOYSA-N |
CAS Registry225521-80-2 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Autoimmune Diseases | Preclinical | United States | 07 Jul 2003 |